Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - tamoxifen citrate - oral tablet - 20mg

США - англійська - NLM (National Library of Medicine)

aurobindo pharma limited - anastrozole (unii: 2z07myw1az) (anastrozole - unii:2z07myw1az) - anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. anastrozole tablets are indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. anastrozole tablets are indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with er-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets. hypersensitivity anastrozole tablets are contraindicated in any patient who has shown a hypersensitivity reaction to the drug or to any of the excipients. observed reactions include anaphylaxis, angioedema, and urticaria [see adverse reactions (6.2)]. risk summary based on findings from animal studies and its mechanism of action, anastrozole may cause fetal harm when admini

Бахрейн - англійська - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - tamoxifen citrate - coated tablet - 10

Канада - англійська - Health Canada

astrazeneca canada inc - tamoxifen (tamoxifen citrate) - tablet - 10mg - tamoxifen (tamoxifen citrate) 10mg - antineoplastic agents

Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astrazeneca sa-nv - tamoxifen citrate 15,2 mg - eq. tamoxifen 10 mg - film-coated tablet - 10 mg - tamoxifen citrate 15.2 mg - tamoxifen

Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astrazeneca sa-nv - tamoxifen citrate 30,4 mg - eq. tamoxifen 20 mg - film-coated tablet - 20 mg - tamoxifen citrate 30.4 mg - tamoxifen

США - англійська - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - anastrozole (unii: 2z07myw1az) (anastrozole - unii:2z07myw1az) - anastrozole 1 mg - anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. anastrozole tablets are indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. anastrozole tablets are indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with er-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets. hypersensitivity anastrozole tablets are contraindicated in any patient who has shown a hypersensitivity reaction to the drug or to any of the excipients. observed reactions include anaphylaxis, angioedema, and urticaria [see adverse reactions (6.2) ]. risk summary based on findings from animal studies and its mechanism of action, anastrozole tablets may cause fetal harm when administered to a pregnant

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - tamoxifen citrate - oral tablet - 20mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - tamoxifen citrate - oral tablet - 20mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - tamoxifen citrate - oral tablet - 20mg